Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05848141 · ClinicalTrials.gov registry record · NA
Rowing Following Breast Cancer Chemotherapy
A NA study of Breast Cancer Survivors, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT05848141: Recruiting NA study of Breast Cancer Survivors, sponsored by University of Florida.
NCT05848141 is a NA study of Breast Cancer Survivors that is actively recruiting participants, run by University of Florida. The registered enrollment target is 72 participants, below the 2,752-participant average among 8 other Breast Cancer Survivors trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05848141, a NA study of Breast Cancer Survivors, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
There are more than 3.8 million breast cancer survivors in the United States and cancer survivors have a higher risk of cardiovascular disease (CVD) due to chemotherapy than adults without cancer. Cardiovascular rehabilitation can be an effective strategy to decrease the incidence of CVD and its risk factors in this population. The proposed study may help to examine the effect of a novel exercise intervention on cardiovascular rehabilitation in breast cancer survivors.
Primary Outcome
Flow-mediated dilation (FMD) is an established non-invasive measure of endothelial function. Brachial artery FMD will be determined via ultrasonography in response to reactive hyperemia following 5-min forearm ischemia.
Conditions Studied
Interventions
- BEHAVIORAL Exercise training
Study Locations (1)
Florida
- Integrative Cardiovasculal Physiology Laboratory, University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT05848141 shows while recruiting
NCT05848141 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 2,752-participant average among 8 other Breast Cancer Survivors trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Breast Cancer Survivors appearing as the primary indexed condition, and to 1 intervention - of which Exercise training is the first listed.
NCT05848141 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05848141 about?
NCT05848141 is a clinical study titled "Rowing Following Breast Cancer Chemotherapy". There are more than 3.8 million breast cancer survivors in the United States and cancer survivors have a higher risk of cardiovascular disease (CVD) due to chemotherapy than adults without cancer. Cardiovascular rehabilitation can be an effective strategy to decrease the incidence of CVD and its ris...
What is the current status of trial NCT05848141?
This trial is currently recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2024-02-26. Estimated completion is 2026-05-31.
What conditions does trial NCT05848141 study?
This clinical trial studies the following conditions: Breast Cancer Survivors.
What interventions are being tested in trial NCT05848141?
The interventions under investigation include: Exercise training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05848141?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05848141 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Survivors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05848141's enrollment target sits among peer trials
72 7th of 8 higher than 2 of 8 other Breast Cancer Survivors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer Survivors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Cognition After Cancer
ACTIVE NOT RECRUITING · NA
-
Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training
ACTIVE NOT RECRUITING · NA
-
Physical Activity Promotion for Breast and Endometrial Cancer Survivors
COMPLETED · NA
-
UCF MammoChat: Image Repository
RECRUITING
-
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)
RECRUITING
-
Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI